MONTREAL, CANADA--(Marketwire - March 17, 2008) - ART Advanced Research Technologies Inc. ("ART") (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, will be exhibiting at the Society of Toxicology (SOT) Annual Meeting, March 17-19, Seattle, WA. ART will showcase its preclinical product offering, including the Optix® MX2 optical imaging device and the Fenestra® line of contrast agents for micro CT imaging at its booth (#1639) located in the Exhibit Hall of the Washington State Convention and Trade Center. In addition, Dr. Joanna Napp from the University of Goettingen in Germany will be presenting recent research using the Optix device in a pancreatic tumor mouse model, to evaluate novel targeted tumor therapies by non-invasive time domain near infrared imaging.
